Inflammatory and autoimmune predictive markers of response to anti-PD-1/PD-L1 therapy in NSCLC and melanoma.

Autor: Musaelyan AA; Laboratory for Diagnostics of Autoimmune Diseases, Center for Molecular Medicine, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia.; Laboratory for Molecular biology, Research Institute of Medical Primatology, Veseloe, Sochi, Krasnodar Territory 354376, Russia., Lapin SV; Laboratory for Diagnostics of Autoimmune Diseases, Center for Molecular Medicine, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia., Urtenova MA; Department of Clinical Oncology, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia., Odintsova SV; Department of Clinical Oncology, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia., Chistyakov IV; Department of Thoracic Surgery, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia., Ulitin AM; Department of Clinical Oncology, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia., Akopov AL; Department of Thoracic Surgery, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia., Orlov SV; Department of Clinical Oncology, Pavlov First Saint Petersburg State Medical University, Saint Petersburg 197022, Russia.; Administration, Research Institute of Medical Primatology, Veseloe, Sochi, Krasnodar Territory 354376, Russia.

Publikováno v: Experimental and therapeutic medicine [Exp Ther Med] 2022 Jul 05; Vol. 24 (3), pp. 557. Date of Electronic Publication: 2022 Jul 05 (Print Publication: 2022).